HomeInsightsPE

Alkem Laboratories Ltd PE Ratio

Alkem Laboratories Ltd PE Ratio

stocks purchased

₹ 0.2 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

0.4 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 22, 2024

Image

Alkem Laboratories Ltd

NSE: ALKEM

PE

30.8

Last updated on: Nov 22, 2024

Key Highlights

  • The P/E Ratio of Alkem Laboratories Ltd is 30.8 as of 22 Nov 13:36 PM .
  • The P/E Ratio of Alkem Laboratories Ltd changed from 27.5 on March 2019 to 32.9 on March 2024 . This represents a CAGR of 3.03% over 6 years.
  • The Latest Trading Price of Alkem Laboratories Ltd is ₹ 5544 as of 22 Nov 13:29 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Alkem Laboratories Ltd

No data available

Company Fundamentals for Alkem Laboratories Ltd

No data available

Image

Alkem Laboratories Ltd

NSE: ALKEM

Share Price

₹ 5544

-59.00 (-1.05%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Alkem Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Alkem Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Nov 20245603
19 Nov 20245525.25
18 Nov 20245508.7
14 Nov 20245522.7
13 Nov 20245574.05
12 Nov 20245501.35
11 Nov 20245619.3
08 Nov 20245701.35
07 Nov 20245721.4
06 Nov 20245852.85

SWOT Analysis Of Alkem Laboratories Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Alkem Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Alkem Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Alkem Laboratories Ltd3066,992
Sun Pharmaceuticals Industries Ltd384,26,518
Divis Laboratories Ltd861,58,636
Cipla Ltd251,18,365
Torrent Pharmaceuticals Ltd601,05,067
Mankind Pharma Ltd481,02,273

Key Valuation Metric of Alkem Laboratories Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Alkem Laboratories Ltd

No data available

* All values are in crore

Historical Revenue of Alkem Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Alkem Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Alkem Laboratories Ltd

No data available

* All values are in crore

Historical Dividend Payout of Alkem Laboratories Ltd

No data available

* All values are in %

About Alkem Laboratories Ltd

  • Headquartered in Mumbai, India, Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations.
  • The company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.
  • The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and international markets.
  • With a portfolio of more than 800 brands in India, Alkem is ranked the fifth largest pharmaceutical company in India in terms of domestic sales.
  • The company also has presence in more than 40 international markets, with the United States being its key focus market. Alkem Laboratories Ltd was incorporated as a private limited company on August 8, 1973 at Patna under the Companies Act, 1956 and subsequently became a deemed public limited company under section 43A(2) of Companies Act, 1956 on October 26, 1988.

Alkem Laboratories Ltd News Hub

News

Alkem Labs PAT soars 90% YoY to Rs 545 crore in Q1

Revenue from operations stood at Rs 3,031.82 crore in June 2024 quarter, registering a gro...

Read more

2024-08-09 00:00:00

News

Alkem Laboratories consolidated net profit rises 90.13% in the June 2024 quarter

Net profit of Alkem Laboratories rose 90.13% to Rs 545.16 crore in the quarter ended June ...

Read more

2024-08-09 00:00:00

News

Alkem Laboratories Ltd soars 3.33%, rises for fifth straight session

Alkem Laboratories Ltd rose for a fifth straight session today. The stock is quoting at Rs...

Read more

2024-08-08 00:00:00

News

Alkem Laboratories Ltd rises for third consecutive session

Alkem Laboratories Ltd gained for a third straight session today. The stock is quoting at ...

Read more

2024-08-06 00:00:00

News

Alkem Laboratories Ltd soars 1.08%, Gains for third straight session

Alkem Laboratories Ltd is up for a third straight session in a row. The stock is quoting a...

Read more

2024-08-28 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Alkem Laboratories Ltd

What is the current PE Ratio of Alkem Laboratories Ltd?

The Current PE Ratio of Alkem Laboratories Ltd is 30.81 as on 22 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 22 Nov 2024.

What was the PE Ratio of Alkem Laboratories Ltd last year?

The PE Ratio of Alkem Laboratories Ltd was 41.28 last year, now the PE ratio is 30.81, showing a year-on-year growth of -25.4%.

What does the PE Ratio of Alkem Laboratories Ltd indicate about its stock?

The PE Ratio of Alkem Laboratories Ltd is 30.81. This ratio indicates that investors are willing to pay 30.81 times the earnings per share for each share of Alkem Laboratories Ltd.

What is the PE Ratio Growth of Alkem Laboratories Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Alkem Laboratories Ltd grew by -25.4% whereas, the EPS ratio grew by 26.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*